Top Epigenetics Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Epigenetics Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Epigenetics industry players.

Epigenetics Market Competitive Landscape

The epigenetics market is characterized by a dynamic and competitive landscape, with a mix of established players and emerging biotech companies driving innovation and growth. Key market participants are increasingly focusing on research and development (R&D) to develop novel epigenetic therapies and diagnostics, capitalizing on the rising interest in personalized medicine and targeted therapies.

Top Players in Epigenetics Market

  • Thermo Fisher Scientific Inc. (United States)
  • Illumina, Inc. (United States) 
  • Merck KGaA (Germany) 
  • QIAGEN N.V. (Netherlands) 
  • Pacific Biosciences of California, Inc. (United States) 
  • Bio-Rad Laboratories, Inc. (United States) 
  • PerkinElmer, Inc. (United States) 
  • 10x Genomics, Inc. (United States) 
  • Active Motif, Inc. (United States) 
  • Zymo Research Corporation (United States) 
  • New England Biolabs, Inc. (United States) 
  • Promega Corporation (United States) 
  • Novartis AG (Switzerland) 
  • Element Biosciences, Inc. (United States) 
  • Dovetail Genomics LLC (United States) 
  • Storm Therapeutics (United Kingdom)

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Epigenetics Market size was valued at USD 1.84 Billion in 2024 and is poised to grow from USD 2.11 Billion in 2025 to USD 6.36 Billion by 2033, growing at a CAGR of 14.8% during the forecast period (2026–2033).

Thermo Fisher Scientific Inc., Illumina, Inc., Merck KGaA, QIAGEN N.V., Pacific Biosciences, Bio-Rad Laboratories, PerkinElmer, 10x Genomics, Active Motif, Zymo Research, New England Biolabs, Promega, Novartis, Element Biosciences, Dovetail Genomics, and Storm Therapeutics.

Rising prevalence of cancer and chronic diseases is driving the Epigenetics Market, as DNA methylation and histone modifications support disease research, diagnostics, and personalized therapies. Increasing investment in precision medicine further strengthens demand for epigenetic products and services.

Advances in epigenetic editing technologies, particularly CRISPR/Cas9-based tools, are enabling precise modification of epigenetic marks without altering underlying DNA, creating new opportunities for research and therapies in cancer, neurological, and autoimmune diseases.

North America accounted for the largest share of the Epigenetics Market, with 38.19% in 2023, supported by strong R&D investments, advanced pharmaceutical infrastructure, rising chronic disease prevalence, public awareness, and the presence of major epigenetics companies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Molecular Cytogenetics Market
Buy Now GET FREE SAMPLE
MicroRNA Market
Buy Now GET FREE SAMPLE
Genomics Market
Buy Now GET FREE SAMPLE
Methyl Ethyl Ketone Market
Buy Now GET FREE SAMPLE
Microarray Market
Buy Now GET FREE SAMPLE
Digital Genome Market
Buy Now GET FREE SAMPLE
Genome Editing Market
Buy Now GET FREE SAMPLE
DNA Synthesis Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Epigenetics Market
Epigenetics Market

Report ID: SQMIG35H2201

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE